Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1β

Charles L Howe, Sonia Mayoral, Moses Rodriguez

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

No therapy currently exists to repair demyelinated lesions in multiple sclerosis. However, the use of IgM antibodies may provide a valuable therapeutic avenue for evoking such repair. Unfortunately, the mechanism of immunoglobulin action in CNS repair is currently unknown but may depend upon complex interactions between multiple cell types rather than upon direct activation of a single cell type. Using rat mixed glial cultures containing oligodendrocytes, microglia, and astrocytes, we found that the Fc portion of human IgM shifts microglia to an activated phenotype, reduces glial proliferation, upregulates a variety of immediate early genes, including JunB, Egr-1, and c-Fos, and stimulates microglial production and release of IL-1β. Microglia-derived IL-1β consequently triggers transcriptional upregulation of immediate early genes such as c-Jun, Egr-1, and c-Fos in the mixed glial cultures, and stimulates the upregulation of late response genes such as lipocalin in purified oligodendrocytes. Treatment with an IL-1β receptor antagonist abrogates the effects of Fcμ on glial proliferation and prevents the upregulation of lipocalin in response to Fcμ, but does not prevent Fcμ-mediated upregulation of IL-1β, suggesting that IL-1β mediates at least some of the downstream effects of Fcμ in mixed glial cultures. We hypothesize that Fcμ-stimulated IL-1β-induced upregulation of immediate early and late response genes in oligodendrocytes may promote CNS repair.

Original languageEnglish (US)
Pages (from-to)731-739
Number of pages9
JournalNeurobiology of Disease
Volume23
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Oligodendroglia
Microglia
Interleukin-1
Neuroglia
Up-Regulation
Lipocalins
Immediate-Early Genes
Immunoglobulin M
Interleukin-1 Receptors
Astrocytes
Genes
Multiple Sclerosis
Immunoglobulins
Phenotype
Antibodies
Therapeutics

Keywords

  • CNS Inflammation
  • Demyelination
  • Fcμ
  • IgM
  • Immunomodulation
  • Interleukin-1β
  • Neural repair
  • Remyelination

ASJC Scopus subject areas

  • Neurology

Cite this

Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1β. / Howe, Charles L; Mayoral, Sonia; Rodriguez, Moses.

In: Neurobiology of Disease, Vol. 23, No. 3, 09.2006, p. 731-739.

Research output: Contribution to journalArticle

@article{27e99da2d5d94c058ebde155dfa9bee8,
title = "Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1β",
abstract = "No therapy currently exists to repair demyelinated lesions in multiple sclerosis. However, the use of IgM antibodies may provide a valuable therapeutic avenue for evoking such repair. Unfortunately, the mechanism of immunoglobulin action in CNS repair is currently unknown but may depend upon complex interactions between multiple cell types rather than upon direct activation of a single cell type. Using rat mixed glial cultures containing oligodendrocytes, microglia, and astrocytes, we found that the Fc portion of human IgM shifts microglia to an activated phenotype, reduces glial proliferation, upregulates a variety of immediate early genes, including JunB, Egr-1, and c-Fos, and stimulates microglial production and release of IL-1β. Microglia-derived IL-1β consequently triggers transcriptional upregulation of immediate early genes such as c-Jun, Egr-1, and c-Fos in the mixed glial cultures, and stimulates the upregulation of late response genes such as lipocalin in purified oligodendrocytes. Treatment with an IL-1β receptor antagonist abrogates the effects of Fcμ on glial proliferation and prevents the upregulation of lipocalin in response to Fcμ, but does not prevent Fcμ-mediated upregulation of IL-1β, suggesting that IL-1β mediates at least some of the downstream effects of Fcμ in mixed glial cultures. We hypothesize that Fcμ-stimulated IL-1β-induced upregulation of immediate early and late response genes in oligodendrocytes may promote CNS repair.",
keywords = "CNS Inflammation, Demyelination, Fcμ, IgM, Immunomodulation, Interleukin-1β, Neural repair, Remyelination",
author = "Howe, {Charles L} and Sonia Mayoral and Moses Rodriguez",
year = "2006",
month = "9",
doi = "10.1016/j.nbd.2006.06.012",
language = "English (US)",
volume = "23",
pages = "731--739",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1β

AU - Howe, Charles L

AU - Mayoral, Sonia

AU - Rodriguez, Moses

PY - 2006/9

Y1 - 2006/9

N2 - No therapy currently exists to repair demyelinated lesions in multiple sclerosis. However, the use of IgM antibodies may provide a valuable therapeutic avenue for evoking such repair. Unfortunately, the mechanism of immunoglobulin action in CNS repair is currently unknown but may depend upon complex interactions between multiple cell types rather than upon direct activation of a single cell type. Using rat mixed glial cultures containing oligodendrocytes, microglia, and astrocytes, we found that the Fc portion of human IgM shifts microglia to an activated phenotype, reduces glial proliferation, upregulates a variety of immediate early genes, including JunB, Egr-1, and c-Fos, and stimulates microglial production and release of IL-1β. Microglia-derived IL-1β consequently triggers transcriptional upregulation of immediate early genes such as c-Jun, Egr-1, and c-Fos in the mixed glial cultures, and stimulates the upregulation of late response genes such as lipocalin in purified oligodendrocytes. Treatment with an IL-1β receptor antagonist abrogates the effects of Fcμ on glial proliferation and prevents the upregulation of lipocalin in response to Fcμ, but does not prevent Fcμ-mediated upregulation of IL-1β, suggesting that IL-1β mediates at least some of the downstream effects of Fcμ in mixed glial cultures. We hypothesize that Fcμ-stimulated IL-1β-induced upregulation of immediate early and late response genes in oligodendrocytes may promote CNS repair.

AB - No therapy currently exists to repair demyelinated lesions in multiple sclerosis. However, the use of IgM antibodies may provide a valuable therapeutic avenue for evoking such repair. Unfortunately, the mechanism of immunoglobulin action in CNS repair is currently unknown but may depend upon complex interactions between multiple cell types rather than upon direct activation of a single cell type. Using rat mixed glial cultures containing oligodendrocytes, microglia, and astrocytes, we found that the Fc portion of human IgM shifts microglia to an activated phenotype, reduces glial proliferation, upregulates a variety of immediate early genes, including JunB, Egr-1, and c-Fos, and stimulates microglial production and release of IL-1β. Microglia-derived IL-1β consequently triggers transcriptional upregulation of immediate early genes such as c-Jun, Egr-1, and c-Fos in the mixed glial cultures, and stimulates the upregulation of late response genes such as lipocalin in purified oligodendrocytes. Treatment with an IL-1β receptor antagonist abrogates the effects of Fcμ on glial proliferation and prevents the upregulation of lipocalin in response to Fcμ, but does not prevent Fcμ-mediated upregulation of IL-1β, suggesting that IL-1β mediates at least some of the downstream effects of Fcμ in mixed glial cultures. We hypothesize that Fcμ-stimulated IL-1β-induced upregulation of immediate early and late response genes in oligodendrocytes may promote CNS repair.

KW - CNS Inflammation

KW - Demyelination

KW - Fcμ

KW - IgM

KW - Immunomodulation

KW - Interleukin-1β

KW - Neural repair

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=33747204588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747204588&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2006.06.012

DO - 10.1016/j.nbd.2006.06.012

M3 - Article

C2 - 16887357

AN - SCOPUS:33747204588

VL - 23

SP - 731

EP - 739

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 3

ER -